{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/12/3311349/0/fr/Communiqu%C3%A9-de-presse-Le-Tzield-de-Sanofi-approuv%C3%A9-aux-%C3%89tats-Unis-comme-premi%C3%A8re-th%C3%A9rapie-modificatrice-de-la-maladie-pour-les-patients-r%C3%A9cemment-diagnostiqu%C3%A9s-avec-un-diab%C3%A8te-de-ty.html", "message": "News view counter 798111 successfully enlarged"}